Mono-2ethylhexyl phthalate (MEHP) is a metabolite of di(2-ethylhexyl) phthalate (DEHP), a common plasticizer used in a variety of consumer products, such as vinyl flooring, medical devices, and personal care items. MEHP is primarily detected through specialized testing, such as a ToxDetect panel, to assess potential exposure to phthalates, which are known endocrine disruptors.
MEHP is used in environmental and health assessments to evaluate the extent of exposure to DEHP, as it is the active compound released when DEHP breaks down in the body. Research has suggested that MEHP and other phthalate metabolites can influence hormone regulation, particularly affecting the reproductive system. Studies have linked elevated levels of MEHP with developmental and hormonal disruptions, including potential risks for fertility, thyroid function, and metabolism.
In a ToxDetect panel, the detection of MEHP can indicate past or ongoing exposure to phthalates, helping healthcare professionals assess potential risks associated with environmental pollutants. While low levels may be common due to widespread phthalate usage in everyday products, high concentrations could raise concerns about the body's ability to detoxify or manage environmental toxins.
Understanding MEHP levels can provide valuable insights into a person's exposure to DEHP and contribute to decision-making regarding lifestyle changes or interventions aimed at reducing exposure to endocrine-disrupting chemicals.
Mono-2ethylhexyl phthalate (MEHP)
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.